Beyond Haemostasis and Thrombosis: Platelets in Depression and Its Co-Morbidities
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Alongside their function in primary haemostasis and thrombo-inflammation, platelets are increasingly considered a bridge between mental, immunological and coagulation-related disorders. This review focuses on the link between platelets and the pathophysiology of major depressive disorder (MDD) and its most frequent comorbidities. Platelet- and neuron-shared proteins involved in MDD are functionally described. Platelet-related studies performed in the context of MDD, cardiovascular disease, and major neurodegenerative, neuropsychiatric and neurodevelopmental disorders are transversally presented from an epidemiological, genetic and functional point of view. To provide a complete scenario, we report the analysis of original data on the epidemiological link between platelets and depression symptoms suggesting moderating and interactive effects of sex on this association. Epidemiological and genetic studies discussed suggest that blood platelets might also be relevant biomarkers of MDD prediction and occurrence in the context of MDD comorbidities. Finally, this review has the ambition to formulate some directives and perspectives for future research on this topic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816
The MR-Base platform supports systematic causal inference across the human phenome
Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959
LD Score regression distinguishes confounding from polygenicity in genome-wide association studies
Schizophrenia Working Group of the Psychiatric Genomics Consortium, Bulik-Sullivan, B. K., Loh, P.-R., Finucane, H. K., Ripke, S., Yang, J., Patterson, N., Daly, M. J., Price, A. L., & Neale, B. M. (2015) · Nature Genetics · doi:10.1038/ng.3211 · Cited by 5,559
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
Davey Smith, G., & Hemani, G. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu328 · Cited by 4,677
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
An atlas of genetic correlations across human diseases and traits
ReproGen Consortium, Bulik-Sullivan, B., Psychiatric Genomics Consortium, Genetic Consortium for Anorexia Nervosa of the Wellcome Trust Case Control Consortium 3, Finucane, H. K., Anttila, V., Gusev, A., Day, F. R., Loh, P.-R., Duncan, L., et al. (2015) · Nature Genetics · doi:10.1038/ng.3406 · Cited by 4,255 · cited 2×
“The authors performed genetic correlation analyses to investigate significant genetic overlaps—better defined as single nucleotide polymorphism (SNP)-based co-heritability [157,158]—between MDD risk and other different disorders and traits, including Plt and MPV.”
BackgroundMethodDepression, chronic diseases, and decrements in health: results from the World Health Surveys
Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Jansen, I. E., Savage, J. E., Watanabe, K., Bryois, J., Williams, D. M., Steinberg, S., Sealock, J., Karlsson, I. K., Hägg, S., Athanasiu, L., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0311-9 · Cited by 2,277
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
The expanded biology of serotonin
Berger, M., Gray, J. A., & Roth, B. L. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.042307.110802 · Cited by 2,100
Neurotrophin regulation of neural circuit development and function
Park, H., & Poo, M.-M. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3379 · Cited by 2,060
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
Ling, S.-C., Polymenidou, M., & Cleveland, D. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.033 · Cited by 1,811 · cited 1×
“This protein is implicated in the onset of the pathology by contributing to the formation of insoluble intracellular inclusions in neurons, and is present in the majority of ALS cases [305,306].”
BackgroundEpidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
Hasin, D. S., Sarvet, A. L., Meyers, J. L., Saha, T. D., Ruan, W. J., Stohl, M., & Grant, B. F. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4602 · Cited by 1,737 · cited 1×
“MDD presents as a persistent low mood, with associated changes in behavior, cognition, sleep and appetite, impaired social and occupational functioning, increased risk of self-harm or suicide [17,18].”
BackgroundThe Relationship of Depression to Cardiovascular Disease: Epidemiology, Biology, and Treatment
Musselman, D. L., Evans, D. L., & Nemeroff, C. B. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.7.580 · Cited by 1,532
Rutledge, T., Reis, V. A., Linke, S. E., Greenberg, B. H., & Mills, P. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.055 · Cited by 1,513
Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis
Barth, J., Schumacher, M., & Herrmann-Lingen, C. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000146332.53619.b2 · Cited by 1,358 · cited 3×
“All these findings were supported by the evidence that an SSRI-treatment decreased platelet aggregation and activity in CAD patients [263,264], and they led to several clinical trials to evaluate the health effects of SSRIs versus placebo or no antidepressants in patients with CHD and depression [265].”
BackgroundNicholson, A., Kuper, H., & Hemingway, H. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl338 · Cited by 1,353
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease
Astle, W. J., Elding, H., Jiang, T., Allen, D., Ruklisa, D., Mann, A. L., Mead, D., Bouman, H., Riveros-Mckay, F., Kostadima, M. A., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.042 · Cited by 1,224
Hackett, M. L., & Pickles, K. (2014) · International Journal of Stroke · doi:10.1111/ijs.12357 · Cited by 1,140
Cognitive decline in Parkinson disease
Aarsland, D., Creese, B., Politis, M., Chaudhuri, K. R., ffytche, D. H., Weintraub, D., & Ballard, C. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.27 · Cited by 1,027 · cited 1×
“In spite of the interesting finding, which is in line with the implication of PDW in neurodegenerative disorders [10,183,187,188] and in comorbid disorders like major depression [149], it should be noted that previous epidemiological studies reported negative associations between PDW and the risk of cognitive impairme…”
ResultAyerbe, L., Ayis, S., Wolfe, C. D. A., & Rudd, A. G. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.107664 · Cited by 980 · cited 1×
“45) [248]; on the other hand, 30% of stroke survivors developed MDD according to two meta-analyses [249,250].”
BackgroundA critical appraisal of amyloid-β-targeting therapies for Alzheimer disease
Panza, F., Lozupone, M., Logroscino, G., & Imbimbo, B. P. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0116-6 · Cited by 965
Jiang, W., Alexander, J., Christopher, E., Kuchibhatla, M., Gaulden, L. H., Cuffe, M. S., Blazing, M. A., Davenport, C., Califf, R. M., Krishnan, R. R., et al. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.15.1849 · Cited by 934 · cited 1×
“Patients with depression had a two- to four-fold higher risk of death after a cardiac event [225,226], and showed higher risk of CVD mortality between 6 and 18 months following MI [227,228].”
BackgroundWhooley, M. A. (2008) · JAMA · doi:10.1001/jama.2008.711 · Cited by 887 · cited 1×
“Beside potential behavioral explanations for this increased risk such as medication noncompliance, cigarette smoking and physical inactivity, other biological factors including a proinflammatory state, endothelial dysfunction and/or platelet activation have been considered [242,252,253].”
BackgroundPenninx, B. W., Milaneschi, Y., Lamers, F., & Vogelzangs, N. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-129 · Cited by 839
Depression and Risk of Stroke Morbidity and Mortality: A Meta-analysis and Systematic Review
Pan, A., Sun, Q., Okereke, O. I., Rexrode, K. M., & Hu, F. B. (2011) · JAMA · doi:10.1001/jama.2011.1282 · Cited by 819
Brain-derived Neurotrophic Factor Is Stored in Human Platelets and Released by Agonist Stimulation
Fujimura, H., Chen, R., Nakamura, T., Nakahashi, T., Kambayashi, J.-I., Sun, B., Altar, C., & Tandon, N. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613072 · Cited by 777 · cited 1×
“BDNF is expressed and stored in human megakaryocyte α-granules together with platelet factor 4 (PF4) [88] and is released by platelets at the site of injury during platelet aggregation [85,89,90], impacting thrombosis [88,91].”
BackgroundMalison, R. T., Price, L. H., Berman, R., van Dyck, C. H., Pelton, G. H., Carpenter, L., Sanacora, G., Owens, M. J., Nemeroff, C. B., Rajeevan, N., et al. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00272-8 · Cited by 496
Association between Mental Disorders and Subsequent Medical Conditions
Momen, N. C., Plana-Ripoll, O., Agerbo, E., Benros, M. E., Børglum, A. D., Christensen, M. K., Dalsgaard, S., Degenhardt, L., de Jonge, P., Debost, J.-C. P. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915784 · Cited by 481 · cited 1×
“Indeed, comorbid depression has been associated with worse prognosis and increased mortality [165,166] and with a higher risk of developing other diseases later in life [167].”
BackgroundHaas, R. H., Nasirian, F., Nakano, K., Ward, D., Pay, M., Hill, R., & Shults, C. W. (1995) · Annals of Neurology · doi:10.1002/ana.410370604 · Cited by 435
Slavich, G. M., & Sacher, J. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05326-9 · Cited by 383 · cited 1×
“The latter should take into account important features such as gender differences that are known to be linked to both platelet variability [313] and to the occurrence of MDD risk [314].”
BackgroundFuchikami, M., Morinobu, S., Segawa, M., Okamoto, Y., Yamawaki, S., Ozaki, N., Inoue, T., Kusumi, I., Koyama, T., Tsuchiyama, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023881 · Cited by 378
Determinants of serum brain-derived neurotrophic factor.
Bus, B. A. A., Molendijk, M. L., Penninx, B. J. W. H., Buitelaar, J. K., Kenis, G., Prickaerts, J., Elzinga, B. M., & Voshaar, R. C. O. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.07.013 · Cited by 279
Laske, C., Stransky, E., Leyhe, T., Eschweiler, G. W., Maetzler, W., Wittorf, A., Soekadar, S., Richartz, E., Koehler, N., Bartels, M., et al. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.01.014 · Cited by 272
Form follows function: BDNF and its involvement in sculpting the function and structure of synapses
Zagrebelsky, M., & Korte, M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.029 · Cited by 241
Benecke, R., Strumper, P., & Weiss, H. (1993) · Brain · doi:10.1093/brain/116.6.1451 · Cited by 220
Mathews, D. C., Henter, I. D., & Zarate, C. A. (2012) · Drugs · doi:10.2165/11633130-000000000-00000 · Cited by 220
Pizzi, C., Rutjes, A. W. S., Costa, G. M., Fontana, F., Mezzetti, A., & Manzoli, L. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.11.017 · Cited by 203
Platelet activation and secretion associated with emotional stress.
Levine, S. P., Towell, B. L., Suarez, A. M., Knieriem, L. K., Harris, M. M., & George, J. N. (1985) · Circulation · doi:10.1161/01.cir.71.6.1129 · Cited by 202 · cited 1×
“Patients with acute stress have been reported to have greater platelet aggregation [308,309].”
BackgroundThe Alzheimer’s Disease Amyloid-Beta Hypothesis in Cardiovascular Aging and Disease
Stakos, D. A., Stamatelopoulos, K., Bampatsias, D., Sachse, M., Zormpas, E., Vlachogiannis, N. I., Tual-Chalot, S., & Stellos, K. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.12.033 · Cited by 188
Brain-derived Neurotrophic Factor in Megakaryocytes
Chacón-Fernández, P., Säuberli, K., Colzani, M., Moreau, T., Ghevaert, C., & Barde, Y.-A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.720029 · Cited by 186 · cited 7×
“An increased oxidative stress and hyperaggregability were observed in platelets of MMD cases compared to controls [141], as well as a higher content of serotonin, interleukin 1β, PF4 and CD40 ligand (CD40L) [142].”
BackgroundInfluentialSmalheiser, N. R., Costa, E., Guidotti, A., Impagnatiello, F., Auta, J., Lacor, P., Kriho, V., & Pappas, G. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1281 · Cited by 158 · cited 1×
“It is not only expressed in the central nervous system, but also in a number of peripheral organs and in blood [103].”
BackgroundMajor depression, cognitive dysfunction and Alzheimer's disease: Is there a link?
Sierksma, A. S. R., van den Hove, D. L. A., Steinbusch, H. W. M., & Prickaerts, J. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.021 · Cited by 139
Chandra, S., Jana, M., & Pahan, K. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.0054-18.2018 · Cited by 134
Increased Coronary Events in Depressed Cardiovascular Patients: 5-HT2A Receptor as Missing Link?
Schins, A., Honig, A., Crijns, H., Baur, L., & Hamulyák, K. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000088596.42029.10 · Cited by 103
Castermans, D., Volders, K., Crepel, A., Backx, L., De Vos, R., Freson, K., Meulemans, S., Vermeesch, J. R., Schrander-Stumpel, C. T. R. M., De Rijk, P., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq013 · Cited by 100
Altered redox state of platelet coenzyme Q 10 in Parkinson's disease
Götz, M. E., Gerstner, A., Harth, R., Dirr, A., Janetzky, B., Kuhn, W., Riederer, P., & Gerlach, M. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050003 · Cited by 93
Remission Rates in Patients With Anxiety Disorders Treated With Paroxetine
Ballenger, J. C. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1216 · Cited by 82
Ding, Y., Huang, L., Xian, X., Yuhanna, I. S., Wasser, C. R., Frotscher, M., Mineo, C., Shaul, P. W., & Herz, J. (2016) · Science Signaling · doi:10.1126/scisignal.aad5578 · Cited by 72 · cited 1×
“On the one hand, reelin is able to foster vascular inflammation via leukocyte–endothelial adhesion, thereby promoting atherosclerosis [104].”
BackgroundChanges in plasma and platelet BDNF levels induced by S-citalopram in major depression
Serra-Millàs, M., López-Vílchez, I., Navarro, V., Galán, A.-M., Escolar, G., Penadés, R., Catalán, R., Fañanás, L., Arias, B., & Gastó, C. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2180-0 · Cited by 67 · cited 1×
“Altered BDNF levels have been found in patients with depression [93,94] and its co-morbidities [95–97].”
BackgroundWysokiński, A., & Szczepocka, E. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.01.034 · Cited by 54 · cited 2×
“Wysokiński and Szczepocka [312] compared platelet parameters like Plt, MPV and P-LCR among 2377 subjects including schizophrenia, depression, bipolar disorder and mania patients and identified several differences among these groups, for all the markers tested.”
BackgroundIncreased of Platelet Indices in Patients with Attention Deficit/Hyperactivity Disorder
Akbayram, S., Gokcen, C., & Karadag, M. (2020) · Psychiatry and Behavioral Sciences · doi:10.5455/pbs.20190912052825 · Cited by 6 · cited 12×
“More recently, also significantly increased PDW in ADHD children compared to controls has been reported, beyond increased levels of Plt, MPV and PCT [171,179,180,186].”
BackgroundInfluential
Cited by
Cheng, Y., Wang, Y., Wang, X., Jiang, Z., Zhu, L., & Fang, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.893097 · Cited by 110
Puangsri, P., & Ninla-aesong, P. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.114216 · Cited by 62
Wei, Y., Feng, J., Ma, J., Chen, D., Xu, H., Yin, L., & Chen, J. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03775-9 · Cited by 48
“Previous studies have found that the abnormalities of the 5-HT receptor in platelets may suggest deficiency of the 5-HT receptor in the central nervous system [10, 11].”
BackgroundWei, Y., Gao, H., Luo, Y., Feng, J., Li, G., Wang, T., Xu, H., Yin, L., Ma, J., & Chen, J. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.10.156 · Cited by 40
Xu, H., Zheng, L., Wang, L., Gao, H., Wei, Y., & Chen, J. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s423399 · Cited by 13
“The reason could be related to the fact that platelet can regulate 5-HT(23) which plays a key role in depression episode.(27) PNI calculated peripheral blood lymphocyte count and albumin concentration as an indicator of the inflammatory response(28) and linked nutritional status to immune response for patients.”
Background
Metadata
- Authors
- Izzi, B., Tirozzi, A., Cerletti, C., Donati, M. B., de Gaetano, G., Hoylaerts, M. F., Iacoviello, L., & Gialluisi, A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-11-21
- Volume
- 21
- Issue
- 22
- Pages
- 8817
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3109790783
- Cited by
- 73
- References
- 54
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.